Carissa Ritner, Northwestern University, discusses her research on neuroblastoma, radiation resistance, miRNA.
Dr. Katherine L. Morel, currently working at the Dana-Farber Cancer Institute, discusses her Radiation Research Editors’ Award article. “Parthenolide Selectively Sensitizes Prostate Tumor Tissue to Radiotherapy while Protecting Healthy Tissues In Vivo” Radiat Res187, 501-12 (2017). https://bioone.org/journals/radiation-research/volume-187/issue-5/RR14710.1/Parthenolide-Selectively-Sensitizes-Prostate-Tumor-Tissue-to-Radiotherapy-while-Protecting/10.1667/RR14710.1.short
Dr. Pierre Montay-Gruel is one of the pioneers studying FLASH radiation. He began his work at the University of Lausanne, Switzerland in Dr. Marie-Catherine Vozenin's lab. There, he studied FLASH effects on the brain and glioblastoma in mice. He is now expanding his research at the University of California- Irvine with Dr. Charles Limoli.
Additional links featured in this podcast:
NIAID: “Concepts: Potential Opportunities”: https://www.niaid.nih.gov/grants-contracts/potential-opportunities
NIH Videocast: https://videocast.nih.gov/
NIAID - subscribe to receive emails: https://service.govdelivery.com/accounts/USNIAID/subscriber/qualify
NIH - Radiation Research program: https://rrp.cancer.gov/default.htm
NIH SBIR and STTR Programs: https://sbir.nih.gov/
NASA Solicitation and Proposal Integrated Review and Evaluation System: https://nspires.nasaprs.com/external/
NIAID Contracts Standard Operating Procedures (SOPs) & resources: https://www.niaid.nih.gov/research/contracts-sops-resources
NASA Human Research Program: https://www.nasa.gov/hrp
FLASH: Charles Limoli, PhD and Marie-Catherine Vozenin, PhD, are interviewed on the surprising effects, how the idea came to fruition and the future of the therapy.